Down-regulation of survivin and hypoxia-inducible factor-1α by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft

Cancer Biotherapy and Radiopharmaceuticals

Volumn 27, Issue 1, 2012, Pages 56-64

  Li, Guoquan ^a   Xie, Bingbing ^a   Li, Xiaolong ^b   Chen, Yinghai ^a   Wang, Qi ^a   Xu, Yinghui ^a   Meng, Xu Welliver ^c   Zou, Lijuan ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b Radiation Oncology Center   (China)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

elemene; HIF 1 ; radioresponse; survivin; xenograft

Indexed keywords

BETA ELEMENE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SURVIVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CURCUMA; DOSE RESPONSE; DOWN REGULATION; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; TRANSCRIPTION REGULATION; TUMOR REGRESSION; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; RADIATION-SENSITIZING AGENTS; SESQUITERPENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84863125777     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2011.1003     Document Type: Article

References (47)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74.
2. Yang H, Wang XP, Yu LL, et al. The antitumor activity of elemene is associated with apoptosis. Chin J Cancer Res 1997;9:83.
3. Wang JW, Zhang HP, Sun Y. Phase IlI clinical trial of elemene emulsion in the management of malignant pleural and peritoneal effusion. Chin J Oncol 1996;18:464.
4. Dong R, Chen X, Wu T, et al. Elemene for the treatment of lung cancer. Cochrane Database Syst Rev 2007;17CD006054.
5. Tan G, Wang ZY, Wang XG, et al. Immunotherapeutic effects of beta-elemene combined with interleukin-23 genemodified dendritic cell on murine pancreatic carcinoma [in Chinese]. Ai Zheng 2006;25:1082.
6. Jiang H, Ma SL, Feng JG. In vitro study of radiosensitization by b-elemene in A549 cell line from adenocarcinoma of lung. Chinese-German J Clin Oncol 2009;8:12.
7. Cheng W, Qiao Z, Shi T, et al. In vitro study on increase in radio sensitivity of renal cell carcinoma induced by b-elemene. Xi'an Jiao Tong Da Xue Xue Bao 2004;25:182.
8. Wu DP, Li XM, Zhao JF, et al. A study of radiosensitivity of belemene to squamous cell carcinoma of tongue Tca-8113 cell line in vitro. Zhong Liu Ji Chu He Lin Chuang 2006;19:116.
9. She JJ, Wang ZM, Che XM, et al. Radiosensitization of betaelemene on VX2 carcinoma transplanted on kidney in rabbits in vivo. Zhong Xi Yi Jie He Xue Bao 2006;4:392.
10. Wu DP, Jiang RB, Zhao DQ, et al. Effects of b-elemene on radiosensitivity, cell cycle, apoptosis, Bcl2 and Bax expression of Tca8113 cells in vitro. Zheng Zou Da Xue Xue Bao 2009;44:414.
11. She JJ, Wang ZM, Chong T, et al. Wang, Expressions of Caspase-3 and Bcl-2 in radio sensitization of b-elemene on rabbit VX2 renal carcinoma. Di Si Jun Yi Da Xue Xue Bao 2006;27:2285.
12. Monzó M, Rosell R, Felip E, et al. A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 1999;17:2100.
13. Altieri DC. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol 2006;18:609.
14. Lens SM, Vader G, Medema RH, The case for Survivin as mitotic regulator. Curr Opin Cell Biol 2006;18:616.
15. Rosa J, Canovas P, Islam A, et al. Survivin modulates microtubule dynamics and nucleation throughout the cell cycle. Mol Biol Cell 2006;17:1483.
16. Dohi T, Xia F, Altieri DC. Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Mol Cell 2007;27:17.
17. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:7212.
18. Manalo DJ, Rowan A, Lavoie T, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005;105:659.
19. Chen YQ, Zhao CL, Li W, et al. Effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer. J Exp Clin Cancer Res 2009;28:29.
20. Chang Q, Qin R, Huang T, et al. Effect of antisense hypoxiainducible factor 1alpha on progression, metastasis, and chemosensitivity of pancreatic cancer. Pancreas 2006;32:297.
21. Peng XH, Karna P, Cao Z, et al. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem 2006;281:25903.
22. Rö del F, Hoffmann J, Grabenbauer GG, et al. High surviving expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection. Strahlenther Onkol 2002;178:426.
23. Bache M, Holzapfel D, Kappler M, et al. Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy. Gynecol Oncol 2007;104:139.
24. Asanuma K, Kobayashi D, Furuya D, et al. A role for surviving in radioresistance of pancreatic cancer cells. Jpn J Cancer Res 2002;93:1057.
25. Vergis R, Corbishley CM, Norman AR, et al. Intrinsic markers of tumour hypoxia and angiogenesis in localized prostate cancer and outcome of radical treatment: A retrospective analysis of two randomised radiotherapy trials and one surgical cohort study. Lancet Oncol 2008;9:342.
26. Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell headand- neck cancer. Int J Radiat Oncol Biol Phys 2002;53:1192.
27. Liu XF, Xia YF, Li MZ, et al. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function. Cell Biol Int 2006;30:283.
28. Milas L, Fujii T, Hunter N, et al. Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Res 1999;59:107.
29. Wang CJ, Zhou ZG, Holmqvist A, et al. Survivin expression quantified by Image Pro-Plus compared with visual assessment. Appl Immunohistochem Mol Morphol 2009;17:530.
30. Qian J, Qin S. Pharmacological and clinical studies of elemene, a new anticancer drug. Chin Clin Cancer 1999; 26:1.
31. Yuan J, Gu ZL, Chou WH, et al. Elemene induces apoptosis and regulates expression of bcl-2 protein in human leukemia K562 cells. Zhongguo Yao Li Xue Bao 1999;20:1036.
32. Zhou H, Shen J, Hou J, et al. Experimental study on apoptosis induced by elemene in glioma cells. Ai Zheng 2003; 22:959.
33. Zou LJ, Liu W, Yu L. ß-Elemene induces apoptosis of K562 leukemia cells. Zhonghua Zhong Liu Za Zhi 2001;23:196.
34. Wang G, Li X, Huang F, et al. Antitumor effect of ß-elemene in non-small cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci 2005;62:881.
35. Zhang Z, Zou LJ, Tian YY. The influence of b-elemene combined with radiotherapy on the expression of DNAPKcs mRNA and apoptosis. Shi Yong Ai Zheng Za Zhi 2009;24:555.
36. Zhang Z, Zou LJ, Tian YY. Effect of b-elemene combined with radiotherapy on the expression of KU70 mRNA and apoptosis of lung adenocarcinoma cell line A549. Zhongguo Zhong Liu Lin Chuang 2010;7:184.
37. Chen P, Li J, Ge LP, et al. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients. Respirology 2010;15:501.
38. Rö del F, Hoffmann J, Distel L, et al. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 2005;65:4881.
39. Asanuma K, Moriai R, Yajima T, et al. Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res 2000;91:1204.
40. Sreevalsan S, Jutooru I, Chadalapaka G, et al. 1,1-Bis(3'- indolyl)-1-(p-bromophenyl) methane and related compounds repress survivin and decrease gamma- radiation-induced survivin in colon and pancreatic cancer cells. Int J Oncol 2009;35 1191.
41. Kami K, Doi R, Koizumi M, et al. Downregulation of surviving by siRNA diminishes radioresistance of pancreatic cancer cells. Surgery 2005;138:299.
42. Konduri S, Colon J, Baker CH, et al. Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression. Mol Cancer Ther 2009;8:533.
43. Moeller BJ, Cao Y, Li CY, et al. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004;5:429.
44. Kim WY, Oh SH, Woo JK, et al. Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia- inducible factor- 1alpha. Cancer Res 2009;69:1624.
45. Gorski DH, Beckett MA, Jaskowiak NT, et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 1999;59:3374.
46. Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003;300:1155.
47. Camphausen K, Moses MA, Beecken WD, et al. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 2001;61:2207.